Over the past two decades, continued improvements in the understanding of HIV, chronic viral hepatitis, haematological malignancies, non-alcoholic steatohepatitis (NASH), inflammatory diseases, invasive fungal infections and emerging viruses have led to the development of significant new treatments, with multiple therapeutic options now available in these disease areas. As a result, many patients are living longer and have an improved quality of life.
However, while much research at a basic science and clinical trial level is focused on drug discovery and evaluation, Gilead recognises that a key part of improving patient care in real terms is the development of approaches to diagnosis, treatment and education at a local practice level. Learnings from successful initiatives can be applied to other communities and/or replicated in other parts of the country, to provide practical solutions to current challenges across these specific therapy areas.
Gilead is committed to supporting innovative local research initiatives to improve patient outcomes. The Research Grants Program enables Australian researchers to apply for funding across a range of therapeutic areas.
The Program aims to support:
Gilead Sciences Pty Ltd is proud to work in partnership with the Australian research and clinical community to provide opportunities for ongoing scientific investigation and research.
Researchers in Australia currently face increasing competition for limited funding, particularly for projects with a local or community focus. In recognition of these projects and their benefits to patient care, the Gilead Australia Fellowship: Research Grants Program aims to help bridge the gap in local Australian research funding.
The Research Grants Program has been running successfully in Australia for close to a decade, providing funding to novel clinical research projects across Australia that can inform and shape best practice in patient care.
Successful applications will focus on investigating solutions to improve outcomes for people living with HIV and/or chronic viral hepatitis, haematological malignancies, NASH, inflammatory diseases, invasive fungal infections and COVID-19.
Projects may be based on sociological and epidemiological aspects of patient care, as well as practical aspects. Applications for community-based projects that may not necessarily fall under traditional research grant criteria are welcomed. Please note that basic science projects are out of scope for the Gilead Australia Fellowship Research Grants Program.
Research proposals are invited that explore and address the following issues and project themes:
The Research Grants Program provides funding for clinical and academic staff at Australian hospitals, clinics, universities and research institutes, young investigators, nurses, GPs and other healthcare providers/researchers from professional organisations, in both urban and rural areas. Applications for community based projects that may not necessarily fall under traditional research grant criteria are welcome. The decision to fund a project will be made by an independent panel and is entirely unrelated to the use of any particular therapeutic agent.
The total funding available for the 2021 Research Grants Program is $300,000 AUD.
The requested level of funding should be stated at the time of application.
Funding is contingent on the project:
* The exact amount of funding allocated to each project may vary depending on the nature of the project. Funding is entirely independent of the use of any particular therapeutic agent.
The applications will be reviewed by a judging panel made up of experts from across Australia recognised for their contributions to research as well as senior Australian public figures. In addition to the Panel, a member of Gilead senior management will be present at the judging sessions.
All applications and supporting documents must be submitted using the online form on the Gilead Australia Fellowship website (www.gileadfellowship.com.au). Please see the Guidance for applicants page for more information.
All applications will be reviewed by the Judging Panel against clear criteria established to ensure balance and relevance. These criteria are set out on the Guidance for applicants page of www.gileadfellowship.com.au.
Each application should demonstrate:
Within a particular project theme, each application should demonstrate:
For the 2021 research grants, preferred projects will also demonstrate engagement with local communities
The website will open for applications on 1 June 2020 and close on 7 August 2020. Please see the Guidance for applicants page for more information.
For more specific application queries, please contact Dr Heshaam Mir, Medical Director at Gilead Sciences at firstname.lastname@example.org.
For technical support please contact Gilead Client Services at email@example.com.
Please note that all queries must be directed as above and applicants may not contact the judges individually.